Vectors for expressing exogenous gene or exogenous nucleic acid sequences
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Nov 22, 2005
filing date -
Jun 4, 2003
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Provided are novel vectors and viral vectors capable of expressing exogenous gene or exogenous nucleic acid sequences in a target cell of interest, such as T cells, bone marrow cells, epithelial cells, liver cells and the like. The nucleic acid components of the vectors may include one or more native promoter/enhancer regions having modified sequence segments, one or more non-native promoter/enhancer or non-native promoter's gene or gene segment, and a native viral vector terminator or processing signal or segment thereof. The viral vectors comprise a virus or viral portion having on the surfaces or envelopes adsorption components, one for a packaging cell line and the other for delivery to a target cell. Other viral vectors provided by this invention have two components on their surfaces or envelopes, one of which is native to the virus and the other being non-native and capable of adsorbing to the target cell while being incapable of adsorbing to a native cell for the viral vector. Packaging cell lines for propagating the vectors and viral vectors are also provided, as are novel processes for propagating any of the disclosed vectors or viral vectors.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
US | B1 | US8703480 | Jan 14, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT AS FIRST PUBLICATION | Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells | Apr 22, 2014 | |||
CA | C | CA2596292 | Mar 20, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
PATENT (SECOND LEVEL) | VECTORS AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME | May 22, 2012 | |||
EP | A1 | EP1005561 | Mar 20, 1998 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION PUBLISHED WITH SEARCH REPORT | VECTOR AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME | Jun 07, 2000 | |||
CA | C | CA2285666 | Mar 20, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
PATENT (SECOND LEVEL) | VECTORS AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME | Dec 14, 2010 | |||
WO | A1 | WO1998042856 | Mar 20, 1998 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT | VECTORS AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME | Oct 01, 1998 | |||
JP | A | JP2001518804 | Mar 20, 1998 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
Published unexamined patent application | VECTORS AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME | Oct 16, 2001 | |||
CA | C | CA2596303 | Mar 20, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
PATENT (SECOND LEVEL) | VECTORS AND VIRAL VECTORS AND PACKAGING CELL LINES FOR PROPOGATING SAME | Sep 24, 2013 | |||
IL | A0 | IL131979 | Mar 20, 1998 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
PATENT APPLICATION FILED | Vectors and viral vectors and packaging cell lines for propagating the same | Jan 01, 1970 | |||
US | B1 | US7439060 | Mar 24, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT AS FIRST PUBLICATION | Independent helper virus packaging cell line for propagating viral vectors | Oct 21, 2008 | |||
US | B1 | US7494806 | Mar 24, 1998 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT AS FIRST PUBLICATION | Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences | Feb 24, 2009 | |||
US | B2 | US7816130 | Jun 04, 2003 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT AS SECOND PUBLICATION | Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences | Oct 19, 2010 | |||
US | A1 | US20060183228 | Sep 28, 2005 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
FIRST PUBLISHED PATENT APPLICATION | Viral vectors with surface or envelope components | Aug 17, 2006 | |||
US | A1 | US20090263895 | Mar 12, 2008 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
FIRST PUBLISHED PATENT APPLICATION | Cell line for producing a non-retroviral vector | Oct 22, 2009 | |||
JP | B2 | JP4733166 | Jun 30, 2008 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
PUBLISHED GRANTED PATENT (SECOND LEVEL) | VECTOR, VIRAL VECTOR, AND PACKAGING CELL LINE FOR PROPAGATING THE SAME | Jul 27, 2011 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
ENZO THERAPEUTICS INC | FARMINGDALE NY 11735 |
International Classification(s)

- 2005 Application Filing Year
- C12N Class
- 2871 Applications Filed
- 1177 Patents Issued To-Date
- 41 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Liu, Dakai | Islip, NY | 45 | 195 |
# of filed Patents : 45 Total Citations : 195 | |||
Rabbani, Elazar | New York, NY | 186 | 2785 |
# of filed Patents : 186 Total Citations : 2785 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- C12N Class
- 0 % this patent is cited more than
- 18 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
